Business Context and Reporting Period
Company: Braskem S.A.
Filing Type: Form 6-K (Earnings Release)
Reporting Period: Third Quarter 2025 (ended September 30, 2025)
Industry: Petrochemicals (Resins and Main Chemicals)
Key Context: The quarter was characterized by a global supply-demand imbalance in the petrochemical industry, record idleness levels in the Brazilian chemical sector (39% YTD), and significant progress in resolving the geological event in Alagoas.
Key Financial Metrics
| Metric | 3Q25 Value | Currency |
|---|---|---|
| Consolidated Recurring EBITDA | 150 million | USD |
| Net Income (Loss) | (1) million | USD |
| Operational Cash Flow | (334) million | BRL |
| Corporate Gross Debt | 8.4 billion | USD |
| Adjusted Net Debt | 7.1 billion | USD |
| Cash Position (ex-Braskem Idesa) | 1.3 billion | USD |
| Available Liquidity (incl. Revolver) | 2.3 billion | USD |
Note: Braskem Idesa (Mexico) reported negative Recurring EBITDA of US$37 million. The Brazil/South America segment reported Recurring EBITDA of US$205 million.
Material Changes vs. Prior Period
- Recurring EBITDA: Increased 104% quarter-over-quarter (vs. 2Q25) to US$150 million, driven by higher sales of main chemicals in Brazil and a strategy prioritizing high-value resin sales. However, it decreased 65% year-over-year (vs. 3Q24) due to lower international spreads and volumes.
- Net Income: Recorded a net loss of US$1 million, primarily due to non-recurring provisions for the Alagoas geological event and the hibernation of the chlor-alkali plant. This contrasts with a net profit of US$66 million year-to-date.
- Segment Performance:
- Brazil/South America: Recurring EBITDA up 35% QoQ. Utilization rate dropped to 65% due to scheduled maintenance in Rio de Janeiro.
- United States & Europe: Recurring EBITDA was negative US$15 million, despite a 2 p.p. gross margin improvement, due to lower demand and feedstock cost impacts.
- Mexico: Recurring EBITDA was negative US$37 million, impacted by maintenance shutdowns and higher ethane import costs.
- Debt & Liquidity: Corporate gross debt remained stable at US$8.4 billion. The company drew down US$1.0 billion on its international revolving credit line in October 2025, bringing total available liquidity to US$2.3 billion.
Guidance, Outlook, Risks, and Unusual Items
Strategic Initiatives & Outlook
- Resilience Program: Management is executing a "Resilience and Transformation Program" to maximize EBITDA and mitigate cash consumption during the industry down cycle.
- Transforma Rio: Board approved a R$4.2 billion investment to expand ethylene and polyethylene capacity in Rio de Janeiro, expected to be completed by end of 2028.
- Regulatory Defense: Strong support for Bill 892/25 (PRESIQ) to provide tax incentives and anti-dumping duties to protect the Brazilian chemical industry.
Risks and Contingencies
- Alagoas Geological Event: A major contingency. On November 10, 2025, Braskem signed a "State Agreement" with the State of Alagoas for a total payment of R$1.2 billion (R$139 million already paid; balance in 10 installments post-2030). This agreement aims to provide full discharge from state-level damages. The remaining provision balance is R$3.8 billion.
- Braskem Idesa Restructuring: In September 2025, Braskem Idesa hired advisors to review its capital structure. Credit ratings were downgraded to 'CCC+' (Fitch) and 'CCC' (S&P) with negative outlooks.
- Market Conditions: Persistent global oversupply of resins (PE, PP, PVC) continues to pressure spreads and utilization rates.
Unusual Items
- Non-Recurring Expenses: Total net expense of R$740 million in "Other Revenue (Expense), Net," including R$524 million for Alagoas provisions, R$252 million for chlor-alkali plant hibernation, and R$208 million for asset sale discounts.
- Rating Downgrades: Braskem S.A. ratings were downgraded to 'CCC+' (Fitch) and 'CCC-' (S&P) in September 2025.
Investor Verification Checklist
- Alagoas Provision Adequacy: Verify if the R$3.8 billion remaining provision is sufficient given the dynamic nature of the geological event and potential future claims not covered by the State Agreement.
- Braskem Idesa Capital Structure: Monitor the outcome of the capital structure review and potential refinancing or restructuring actions for the Mexico subsidiary.
- Regulatory Approval: Track the progress of Bill 892/25 (PRESIQ) in the Brazilian Senate and the finalization of anti-dumping duties on PE imports.
- Debt Maturity: Confirm the company's ability to service US$8.4 billion in debt with an average term of 9 years amidst current cash consumption levels.
- Transforma Rio Financing: Assess the feasibility of securing the necessary financing for the R$4.2 billion expansion project given current credit ratings.